Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H12FN5O4 |
| Molecular Weight | 285.2318 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC(F)=NC2=C1N=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
InChI
InChIKey=HBUBKKRHXORPQB-UUOKFMHZSA-N
InChI=1S/C10H12FN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6-,9-/m1/s1
| Molecular Formula | C10H12FN5O4 |
| Molecular Weight | 285.2318 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
2-Fluoroadenosine (F-Ado) was developed at Southern Research Institute in 1957 as a potential anticancer drug. 2-Fluoroadenosine is not deaminated by adenosine deaminase but metabolized to triphosphate as shown in vitro. The drug was also shown to be a potent inhibitor of lymphocyte-mediated cytolysis.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Purine analogs as potential anticytomegalovirus agents. | 1969 Sep |
|
| Nicotinamide 2-fluoroadenine dinucleotide unmasks the NAD+ glycohydrolase activity of Aplysia californica adenosine 5'-diphosphate ribosyl cyclase. | 2007 Apr 3 |
|
| [(3)H]Adenine is a suitable radioligand for the labeling of G protein-coupled adenine receptors but shows high affinity to bacterial contaminations in buffer solutions. | 2007 Sep |
|
| Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT. | 2009 Dec 3 |
|
| [The preparative method for 2-fluoroadenosine synthesis]. | 2009 Mar-Apr |
Patents
Sample Use Guides
The cytotoxic lymphocytes (2.5*10(5) cells/ml) were preincubated for 60 min at 37 degree Celsius with 2-fluoroadenosine at concentrations from 0.5 to 50 uM and then the mixture was added to EL4 cells. IC50 for the inhibition of cytolysis was 6.1 uM. In a preliminary test, 2-fluoroadenosine inhibited the growth of Human Epidermoid Carcinoma at 10(-8) g./ml.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:54:06 GMT 2023
by
admin
on
Fri Dec 15 17:54:06 GMT 2023
|
| Record UNII |
0S67290CRJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
39740
Created by
admin on Fri Dec 15 17:54:06 GMT 2023 , Edited by admin on Fri Dec 15 17:54:06 GMT 2023
|
PRIMARY | |||
|
30605
Created by
admin on Fri Dec 15 17:54:06 GMT 2023 , Edited by admin on Fri Dec 15 17:54:06 GMT 2023
|
PRIMARY | |||
|
DB04441
Created by
admin on Fri Dec 15 17:54:06 GMT 2023 , Edited by admin on Fri Dec 15 17:54:06 GMT 2023
|
PRIMARY | |||
|
DTXSID70163252
Created by
admin on Fri Dec 15 17:54:06 GMT 2023 , Edited by admin on Fri Dec 15 17:54:06 GMT 2023
|
PRIMARY | |||
|
8975
Created by
admin on Fri Dec 15 17:54:06 GMT 2023 , Edited by admin on Fri Dec 15 17:54:06 GMT 2023
|
PRIMARY | |||
|
C034064
Created by
admin on Fri Dec 15 17:54:06 GMT 2023 , Edited by admin on Fri Dec 15 17:54:06 GMT 2023
|
PRIMARY | |||
|
0S67290CRJ
Created by
admin on Fri Dec 15 17:54:06 GMT 2023 , Edited by admin on Fri Dec 15 17:54:06 GMT 2023
|
PRIMARY | |||
|
146-78-1
Created by
admin on Fri Dec 15 17:54:06 GMT 2023 , Edited by admin on Fri Dec 15 17:54:06 GMT 2023
|
PRIMARY |